-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
A3N19
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2249755-49-3.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2249755-49-3 |
| Description | A3N19 is a potent HIV-1 non-nucleoside reverse transcriptase inhibitor, with an EC50 of 3.28 nM against HIV-1 IIIB. |
Product Information
| Synonyms | A3N19|CHEMBL4752774|HY-146031|CS-0497849 |
| Molecular Weight | 593.7 |
| Molecular Formula | C31H31N9O2S |
| Canonical SMILES | CC1=CC(=CC(=C1OC2=NC(=NC3=C2SC=C3)NC4CCN(CC4)CC5=CN(N=N5)CC6=CC=C(C=C6)C(=O)N)C)C#N |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 970 |
| Exact Mass | 593.23214244 |
| Target | HIV |
| XLogP3-AA | 4.3 |
